Skip to Main Content

Author Details

Konstantinos N Lazaridis
Mayo Clinic
1997
157
44
PMIDPaper TitleJournal TitlePublished Year
38072827Most patients with disorders of gut-brain interaction receive pharmacotherapy with major or moderate drug-gene interactions.Neurogastroenterol Motil2024
36253919Incorporation of Genetic Studies in the Kidney Transplant Evaluation Clinic: The Value of a Multidisciplinary Approach.Transplantation2023
37886596IL-17 Signaling in Primary Sclerosing Cholangitis Patient-Derived Organoids.Res Sq2023
37353797Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD).J Transl Med2023
37076803Predicting cholangiocarcinoma in primary sclerosing cholangitis: using artificial intelligence, clinical and laboratory data.BMC Gastroenterol2023
36889360The exposome and liver disease - how environmental factors affect liver health.J Hepatol2023
36745126Impact of integrated translational research on clinical exome sequencing.Genet Med2023
36687160Environmental chemicals and endogenous metabolites in bile of USA and Norway patients with primary sclerosing cholangitis.Exposome2023
36639314Corrigendum to: "An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs" [J Hepatol 75 (2021) 572-581].J Hepatol2023
33939140Patients with Autoimmune Hepatitis Report Lower Lifetime Coffee Consumption.Dig Dis Sci2022
35473391DNA methylation profile of liver tissue in end-stage cholestatic liver disease.Epigenomics2022
35861636ACE2 and TMPRSS2 SARS-CoV-2 infectivity genes: deep mutational scanning and characterization of missense variants.Hum Mol Genet2022
36396865Algebraic topology-based machine learning using MRI predicts outcomes in primary sclerosing cholangitis.Eur Radiol Exp2022
36263124Network science approach elucidates integrative genomic-metabolomic signature of antidepressant response and lifetime history of attempted suicide in adults with major depressive disorder.Front Pharmacol2022
35331649Implementation of preemptive DNA sequence-based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K Study.Genet Med2022
34825528High-Resolution Exposomics and Metabolomics Reveals Specific Associations in Cholestatic Liver Diseases.Hepatol Commun2022
34671112Nine-gene pharmacogenomics profile service: The Mayo Clinic experience.Pharmacogenomics J2022
34519176Induced Pluripotent Stem Cells From Subjects With Primary Sclerosing Cholangitis Develop a Senescence Phenotype Following Biliary Differentiation.Hepatol Commun2022
32974892Early Cholangiocarcinoma Detection With Magnetic Resonance Imaging Versus Ultrasound in Primary Sclerosing Cholangitis.Hepatology2021
33794792Evaluation of circulating cell-free DNA in cholestatic liver disease using liver-specific methylation markers.BMC Gastroenterol2021
33539039Discovery and Opportunities With Integrative Analytics Using Multiple-Omics Data.Hepatology2021
33890576Clinically Actionable Findings Derived From Predictive Genomic Testing Offered in a Medical Practice Setting.Mayo Clin Proc2021
34552080A scalable workflow to characterize the human exposome.Nat Commun2021
34746741Genomics Integration Into Nephrology Practice.Kidney Med2021
34563121The PSC scientific community resource: an asset for multi-omics interrogation of primary sclerosing cholangitis.BMC Gastroenterol2021
34120753Identification of Genetic Causes of Focal Segmental Glomerulosclerosis Increases With Proper Patient Selection.Mayo Clin Proc2021
33978301Environmental risk factors are associated with autoimmune hepatitis.Liver Int2021
33144682Impact of integrated translational research on clinical exome sequencing.Genet Med2021
33226645Bile Acid Profiles in Primary Sclerosing Cholangitis and Their Ability to Predict Hepatic Decompensation.Hepatology2021
29742811Primary Sclerosing Cholangitis Risk Estimate Tool (PREsTo) Predicts Outcomes of the Disease: A Derivation and Validation Study Using Machine Learning.Hepatology2020
31701542Studying the Exposome to Understand the Environmental Determinants of Complex Liver Diseases.Hepatology2020
31932891An update on primary sclerosing cholangitis epidemiology, outcomes and quantification of alkaline phosphatase variability in a population-based cohort.J Gastroenterol2020
31925805Genomic Characterization of Cholangiocarcinoma in Primary Sclerosing Cholangitis Reveals Therapeutic Opportunities.Hepatology2020
31683058Changes in Liver Stiffness, Measured by Magnetic Resonance Elastography, Associated With Hepatic Decompensation in Patients With Primary Sclerosing Cholangitis.Clin Gastroenterol Hepatol2020
33203829Functional validation of TERT and TERC variants of uncertain significance in patients with short telomere syndromes.Blood Cancer J2020
32914644Genome-wide resolution peripheral blood methylome profiling reveals signatures for cholestatic liver disease.Epigenomics2020
32934239A predictive index for health status using species-level gut microbiome profiling.Nat Commun2020
32724082Single-cell mass cytometry on peripheral blood identifies immune cell subsets associated with primary biliary cholangitis.Sci Rep2020
30616022Effects of Age and Sex of Response to Ursodeoxycholic Acid and Transplant-free Survival in Patients With Primary Biliary Cholangitis.Clin Gastroenterol Hepatol2019
32025330Metabolomic biomarkers are associated with mortality in patients with cirrhosis caused by primary biliary cholangitis or primary sclerosing cholangitis.Future Sci OA2019
31256854Clinical Applications and Utility of a Precision Medicine Approach for Patients With Unexplained Cytopenias.Mayo Clin Proc2019
31000362Individualized medicine comes to the liver clinic.J Hepatol2019
31019553Cell-free DNA testing: future applications in gastroenterology and hepatology.Therap Adv Gastroenterol2019
30520030PACE Forward-Making Pharmacogenomics Testing Available for Real-Life Clinical Utility.Clin Pharmacol Ther2019
28779025Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis.Gut2018
30217743Whole Exome Sequencing Leading to Novel Therapeutic Discovery.Gastroenterology2018
29881819External validation of the United Kingdom-primary biliary cholangitis risk scores of patients with primary biliary cholangitis treated with ursodeoxycholic acid.Hepatol Commun2018
30332763Metabolomic Profiling of Portal Blood and Bile Reveals Metabolic Signatures of Primary Sclerosing Cholangitis.Int J Mol Sci2018
29474507PNPLA3 Association with Alcoholic Liver Disease in a Cohort of Heavy Drinkers.Alcohol Alcohol2018
29592893Recurrent STAT3-JAK2 fusions in indolent T-cell lymphoproliferative disorder of the gastrointestinal tract.Blood2018
  • 1 - 50 of 157

Recommended Authors

Min Kyu Kang
Yeungnam University College of Medicine
Career Start Year 2018
Number of shared co-authors 0
Khashayar Asadi
Austin Hospital
Career Start Year 2015
Number of shared co-authors 0
Anouar Teriaky
Western University
Career Start Year 2011
Number of shared co-authors 0
Neil Rajoriya
Queen Elizabeth Hospital Birmingham
Career Start Year 2009
Number of shared co-authors 1
Christopher Koh
Clinical Research Section
Career Start Year 2008
Number of shared co-authors 3
Bita V Naini
university of california los angeles Medical Center
Career Start Year 2008
Number of shared co-authors 0
Jung Gil Park
Yeungnam University Hospital
Career Start Year 2006
Number of shared co-authors 0
Thomas Longerich
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2004
Number of shared co-authors 7
Mayur Brahmania
Cumming School of Medicine
Career Start Year 2004
Number of shared co-authors 0
Thomas J Urban
Eshelman School of Pharmacy, University of North Carolina
Career Start Year 2003
Number of shared co-authors 1
Elie Aoun
Columbia University
Career Start Year 2002
Number of shared co-authors 0
Michael Icardi
University of Iowa
Career Start Year 2002
Number of shared co-authors 0
Richard Gilroy
Intermountain Medical Center
Career Start Year 2000
Number of shared co-authors 0
Curtis K Argo
University of Virginia
Career Start Year 2000
Number of shared co-authors 0
Ali Zarrinpar
College of Medicine, University of Florida
Career Start Year 1999
Number of shared co-authors 0
Arief A Suriawinata
Dartmouth Hitchcock Medical Center
Career Start Year 1999
Number of shared co-authors 3
Frank Tacke
Charite-Universitatsmedizin Berlin
Career Start Year 1999
Number of shared co-authors 3
Fedja A Rochling
University of Nebraska Medical Center
Career Start Year 1997
Number of shared co-authors 2
Theo Heller
National Institute of Diabetes and Digestive and Kidney Diseases
Career Start Year 1996
Number of shared co-authors 3
Peter St??rkel
Cliniques Universitaires Saint-Luc (CUSL)
Career Start Year 1996
Number of shared co-authors 0
James E Squires
UPMC Children's Hospital of Pittsburgh.
Career Start Year 1995
Number of shared co-authors 0
Andrew D Clouston
University of Queensland
Career Start Year 1993
Number of shared co-authors 3
Christine M Hunt
Duke University Medical Center and Durham Veterans Affairs Health Care System
Career Start Year 1990
Number of shared co-authors 0
Hector Melin-Aldana
Ann & Robert H. Lurie Children's Hospital of Chicago
Career Start Year 1990
Number of shared co-authors 0
Grace L Su
University of Washington
Career Start Year 1989
Number of shared co-authors 0
Arun J Sanyal
Virginia Commonwealth University
Career Start Year 1989
Number of shared co-authors 4
Yoshiyuki Takei
Mie University
Career Start Year 1988
Number of shared co-authors 0
Samuel B Ho
College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences
Career Start Year 1983
Number of shared co-authors 1
Zachary Goodman
Center for Liver Diseases, Inova Fairfax Hospital
Career Start Year 1975
Number of shared co-authors 2
Ronald J Sokol
Digestive Health Institute, Children's Hospital Colorado
Career Start Year 1964
Number of shared co-authors 2

Collaborators

Brian D Juran
Mayo Clinic
Co-authored papers 57
Elizabeth J Atkinson
Mayo Clinic
Co-authored papers 26
Eric W Klee
Mayo Clinic College of Medicine and Science
Co-authored papers 19
Gideon M Hirschfield
University of Toronto
Co-authored papers 16
Alexander Keith Stewart
Co-authored papers 10
Bryan M McCauley
Division of Clinical Trials and Biostatistics, Mayo Clinic
Co-authored papers 10
Andre Franke
Institute of Clinical Molecular Biology, Kiel University
Co-authored papers 9
Mariza de Andrade
Mayo Clinic
Co-authored papers 9
Gianrico Farrugia
Mayo Clinic Gastroenterology and Hepatology, Mayo Clinic
Co-authored papers 8
Pietro Invernizzi
Center for Autoimmune Liver Diseases, University of Milano-Bicocca
Co-authored papers 8
David Ellinghaus
Co-authored papers 7
Katherine A Siminovitch
University of Toronto, Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital
Co-authored papers 7
Alan H Bryce
Mayo Clinic
Co-authored papers 6
Robert W Williams
Mayo Clinic
Co-authored papers 6
Eric D Wieben
Mayo Clinic Rochester
Co-authored papers 6
Christopher I Amos
Baylor College of Medicine
Co-authored papers 6
Matthew J Ferber
Mayo Clinic
Co-authored papers 6
Pavel N Pichurin
Mayo Clinic
Co-authored papers 6
Stefan Schreiber
Co-authored papers 6
Lewis R Roberts
Co-authored papers 5
Michael R Henry
Mayo Clinic
Co-authored papers 5
Richard N Sandford
University of Cambridge
Co-authored papers 5
Joseph J Larson
Division of Clinical Trials and Biostatistics, Mayo Clinic
Co-authored papers 4
Carl A Anderson
Wellcome Sanger Institute
Co-authored papers 4
Jennifer B McCormick
Penn State College of Medicine
Co-authored papers 4
Cisca Wijmenga
Co-authored papers 4
Piet C de Groen
University of Minnesota
Co-authored papers 4
Gang Xie
Chaohu Hospital Affiliated to Anhui Medical University
Co-authored papers 4
Scott A Beck
Center for Individualized Medicine, College of Medicine, Mayo Clinic
Co-authored papers 4
Carolyn R Rohrer Vitek
Center for Individualized Medicine, College of Medicine, Mayo Clinic
Co-authored papers 4
Release 1.2